Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 3
2010 1
2014 1
2015 10
2016 6
2017 8
2018 11
2019 12
2020 9
2021 14
2022 11
2023 13
2024 14
2025 15
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, Arun B, Buys SS, Cheng H, Domchek SM, Friedman S, Giri V, Goggins M, Hagemann A, Hendrix A, Hutton ML, Karlan BY, Kassem N, Khan S, Khoury K, Kurian AW, Laronga C, Mak JS, Mansour J, McDonnell K, Menendez CS, Merajver SD, Norquist BS, Offit K, Rash D, Reiser G, Senter-Jamieson L, Shannon KM, Visvanathan K, Welborn J, Wick MJ, Wood M, Yurgelun MB, Dwyer MA, Darlow SD. Daly MB, et al. J Natl Compr Canc Netw. 2023 Oct;21(10):1000-1010. doi: 10.6004/jnccn.2023.0051. J Natl Compr Canc Netw. 2023. PMID: 37856201
Breast Cancer Surgery-Fast-Paced and ever-Changing.
Al-Hilli Z, Weiss A. Al-Hilli Z, et al. Clin Breast Cancer. 2024 Dec;24(8):661-662. doi: 10.1016/j.clbc.2024.07.004. Epub 2024 Jul 10. Clin Breast Cancer. 2024. PMID: 39117503 No abstract available.
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026.
Cheng HH, Giri VN, Goggins M, Yurgelun MB, Karlan BY, Norquist BS, Daly MB, Pal T, AlHilli Z, Arun B, Churpek J, Colonna S, Domchek SM, Escobar MR, Fejerman L, Friedman S, Hagemann A, Hendrix A, Huo D, Hutton ML, Kassem N, Khan S, Kurian AW, Laronga C, Mak JS, Maxwell KN, McDonnell K, Merajver SD, Mersch J, Offit K, Plichta J, Rash D, Reiser G, Senter-Jamieson L, Shannon KM, Welborn J, Wick MJ, Wood M, Darlow S, Diwan Z, Dwyer M. Cheng HH, et al. J Natl Compr Canc Netw. 2026 Feb;24(2):2-10. doi: 10.6004/jnccn.2026.0007. J Natl Compr Canc Netw. 2026. PMID: 41671423
Reducing the risk of breast cancer.
Pederson HJ, Al-Hilli Z, Kurian AW. Pederson HJ, et al. Among authors: al hilli z. Cleve Clin J Med. 2022 Nov 1;89(11):643-652. doi: 10.3949/ccjm.89a.21113. Cleve Clin J Med. 2022. PMID: 36319046 Free article. Review.
Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates.
Vicini F, Shah C, Mittal K, Weinmann S, Leo M, Mann GB, Warnberg F, Rabinovitch R, Czerniecki B, Meattini I, Khan AJ, Jhawar S, Gerber N, Willey SC, Borgen P, AlHilli Z, Kruse M, Dabbs D, Shivers SC, Daily A, Whitworth P, Alvarado M, Mouabbi JA, Moran M, Rugo H, O'Shaughnessy JA, Bremer T. Vicini F, et al. Int J Radiat Oncol Biol Phys. 2025 Nov 15;123(4):1090-1101. doi: 10.1016/j.ijrobp.2025.07.1411. Epub 2025 Jul 18. Int J Radiat Oncol Biol Phys. 2025. PMID: 40685017 Free article.
108 results